Full-Time

Clinical Research Associate 2 / Senior Clinical Research Associate

Pain Management

Rho

Rho

501-1,000 employees

Comprehensive CRO for regulatory drug approvals

Compensation Overview

$90k - $140k/yr

Remote in USA

Remote

Must live within a 1-hour commute of a U.S. metropolitan airport; requires 8–10 site-visit days per month and up to 80% travel.

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Microsoft Office
Medical Terminology

Get referred to Rho

See people who can refer or advise you

Requirements
  • A Bachelor of Arts or Bachelor of Science degree, preferably in life science, nursing, pharmacy, or a related field.
  • Approximately 2 years of on-site monitoring experience for a Clinical Research Associate II or 4–5 or more years for a Senior Clinical Research Associate within the contract research organization, pharmaceutical, or biotechnology industry.
  • Demonstrated understanding of medical or therapeutic-area knowledge and medical terminology sufficient to comprehend and execute clinical protocols.
  • Computer literacy, including proficiency in Microsoft Office and use of electronic data capture systems.
  • Written, verbal, and presentation skills.
  • Strong organizational skills and the ability to manage multiple sites and protocols within timeframes and budgets.
Responsibilities
  • Perform all site-monitoring visit activities, including pre-study visits, site initiation visits, interim monitoring visits, and close-out visits.
  • Participate in the site-selection process with oversight from the Clinical Team Lead.
  • Provide feedback to help sites resolve detected deficiencies and implement corrective actions, and follow up until deficiencies are resolved.
  • Contribute to the development and review of protocols, study tools, materials, and clinical-trial documentation.
  • Provide mentoring, training, and co-monitoring for junior clinical team members.
  • Develop and maintain effective working relationships with clinical sites and internal teams, and ensure communication of project goals and critical requirements.
  • Attend and present at meetings and conferences, including investigator meetings.
  • Participate in the request-for-proposal process, including business-development meetings.
  • Contribute to internal clinical-operations initiatives and standard operating procedures for the administration and monitoring of clinical trials.
  • Perform on-site and remote monitoring and study-closure activities across multiple protocols.
  • Conduct site visits to assess site adherence to protocols and regulatory requirements, manage required documentation, and ensure data are audit-ready and able to pass audits by the company, sponsor, or regulatory agency.

Rho is a contract research organization that provides end-to-end development and regulatory services for drugs, biologics, and medical devices. Clients range from small biotech startups to large pharma, relying on Rho to plan and run clinical development, regulatory strategy, and submissions for NDAs, BLAs, and MAAs. The company supports decentralized clinical trials and infectious-disease programs, offering integrated expertise across study design, data management, and regulatory affairs. Its goal is to help clients bring products to market efficiently by navigating regulatory requirements and streamlining development and submission processes.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Durham, North Carolina

Founded

1984

Get referred to Rho

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Sharp’s July 2025 engagement extends Rho into rare-disease development and submission work.
  • Tonix’s February 2024 NDA engagement validates Rho’s value in late-stage regulatory execution.
  • Rho’s news page updated March 16, 2026 signals active business development and current operations.

What critics are saying

  • Biotech funding drought hits Rho’s small-client base; Sharp and Tonix depend on capital markets.
  • Rho’s recent public visibility is thin; no 2025-2026 flagship contract announcement surfaced.
  • Large CROs like IQVIA and PPD compress pricing, squeezing Rho’s mid-market positioning.

What makes Rho unique

  • Rho’s 1984 heritage and RTP base anchor deep regulatory and clinical expertise.
  • Tonix chose Rho in February 2024 for NDA submission support.
  • Sharp Therapeutics hired Rho in July 2025 for Gaucher IND preparation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

6%

1 year growth

6%

2 year growth

6%
Rho, Inc
Apr 25th, 2022
Rho, Inc. hired Peter Schmidt as SVP, Government Partnerships, Executive Committee Member Research on Apr 19th 22'.

Rho Appoints Peter Schmidt, Ph.D., as SVP, Government Partnerships, Executive Committee Member Research Triangle Park, NC – April 19, 2022 – Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, has appointed Peter Schmidt, Ph.D., as Senior Vice President, Government Partnerships of Rho’s Federal Systems Division.

Rho, Inc
Feb 10th, 2022
Rho, Inc. hired Gladwell as COO on May 1st 21'.

Ms. Gladwell was appointed as COO of Rho in May 2021.

Rho, Inc
Jan 12th, 2022
Rho, Inc. promoted Mark Ubert to Chief Financial Officer on Jan 12th 22'.

Research Triangle Park, NC – January 12, 2022 – Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, has promoted Mark Ubert, MBA, to the position of Chief Financial Officer (CFO).